THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Jad Kebbe

Concepts (84)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bronchoscopy
5
2019
35
2.320
Why?
Airway Obstruction
2
2016
19
1.000
Why?
Lung
2
2019
376
0.920
Why?
Biopsy
2
2019
207
0.760
Why?
Hemothorax
1
2019
2
0.650
Why?
Cryosurgery
1
2019
19
0.640
Why?
Visitors to Patients
1
2019
1
0.640
Why?
Lung Diseases, Interstitial
1
2019
19
0.640
Why?
Thoracic Surgical Procedures
1
2019
5
0.640
Why?
Bronchial Fistula
1
2017
1
0.550
Why?
Hemoptysis
1
2017
2
0.550
Why?
Esophageal Fistula
1
2017
2
0.550
Why?
Aspirin
2
2016
124
0.550
Why?
Calcinosis
1
2017
25
0.540
Why?
Lung Abscess
1
2016
1
0.520
Why?
Professional-Family Relations
1
2016
22
0.520
Why?
Therapeutic Occlusion
1
2016
1
0.510
Why?
Pneumonia
1
2017
89
0.510
Why?
Scimitar Syndrome
1
2016
6
0.510
Why?
Intensive Care Units
1
2016
50
0.510
Why?
Pulmonary Artery
1
2016
69
0.490
Why?
Cardiac Catheterization
1
2016
113
0.490
Why?
Aorta
1
2016
124
0.480
Why?
Quality of Life
1
2019
492
0.470
Why?
Carcinoma
1
2015
75
0.460
Why?
Prasugrel Hydrochloride
1
2015
18
0.460
Why?
Coronary Restenosis
1
2015
21
0.460
Why?
Cisplatin
1
2015
179
0.460
Why?
Carcinoma, Non-Small-Cell Lung
1
2015
105
0.440
Why?
Carcinoma, Squamous Cell
1
2015
164
0.410
Why?
Adenocarcinoma
1
2015
297
0.400
Why?
Breast Neoplasms
1
2016
464
0.350
Why?
Lung Neoplasms
1
2015
356
0.350
Why?
Tomography, X-Ray Computed
3
2019
477
0.350
Why?
Male
8
2019
13510
0.340
Why?
Antineoplastic Agents
1
2015
678
0.330
Why?
Treatment Outcome
4
2017
2383
0.320
Why?
Humans
11
2022
28167
0.280
Why?
Middle Aged
5
2019
7164
0.270
Why?
Platelet Aggregation Inhibitors
2
2016
191
0.220
Why?
Adult
4
2019
7765
0.190
Why?
Aged
3
2019
5416
0.170
Why?
Patient Comfort
1
2019
1
0.160
Why?
Family Relations
1
2019
11
0.160
Why?
Fluoroscopy
1
2019
35
0.160
Why?
Cold Temperature
1
2019
34
0.160
Why?
Ultrasonography, Interventional
1
2019
39
0.150
Why?
Patient Care Team
1
2019
66
0.150
Why?
Diagnosis, Differential
1
2019
372
0.150
Why?
Mediastinal Diseases
1
2017
2
0.140
Why?
Female
4
2019
15191
0.140
Why?
Endoscopy, Digestive System
1
2017
20
0.140
Why?
Collateral Circulation
1
2016
12
0.130
Why?
Diuretics
1
2016
12
0.130
Why?
Angiography
1
2016
35
0.130
Why?
Radiography, Thoracic
1
2016
12
0.130
Why?
Magnetic Resonance Imaging, Cine
1
2016
8
0.130
Why?
Bronchodilator Agents
1
2016
15
0.130
Why?
Recurrence
1
2017
323
0.130
Why?
Family
1
2016
98
0.120
Why?
Echocardiography
1
2016
108
0.120
Why?
Stents
1
2016
121
0.120
Why?
Hemodynamics
1
2016
220
0.120
Why?
Coronary Stenosis
1
2015
19
0.120
Why?
Pneumonectomy
1
2015
11
0.120
Why?
Biopsy, Needle
1
2015
48
0.120
Why?
Postoperative Complications
1
2019
613
0.120
Why?
Monitoring, Physiologic
1
2015
57
0.110
Why?
Patient Safety
1
2015
38
0.110
Why?
Angioplasty, Balloon, Coronary
1
2015
52
0.110
Why?
Radiography
1
2015
203
0.110
Why?
Hemorrhage
1
2016
265
0.110
Why?
Drug-Eluting Stents
1
2015
102
0.110
Why?
Risk Assessment
1
2015
611
0.100
Why?
Neoplasm Recurrence, Local
1
2015
330
0.100
Why?
Follow-Up Studies
1
2015
1015
0.100
Why?
Dexamethasone
1
2022
63
0.050
Why?
Oxygen
1
2022
234
0.040
Why?
Disease Management
1
2021
88
0.040
Why?
Pandemics
1
2021
186
0.040
Why?
Risk
1
2016
137
0.030
Why?
Age Factors
1
2016
733
0.030
Why?
Aged, 80 and over
1
2016
2021
0.020
Why?
Retrospective Studies
1
2016
2558
0.020
Why?
Kebbe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (84)
Explore
_
Co-Authors (7)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES